Want to see SE:IMMU full AI Analyst Report?
Immunicum AB (IMMU) Income Statement
Immunicum AB Income Statement
Last quarter (Q2 2026), Immunicum AB's total revenue was $0.00. In Q2, Immunicum AB's net income was $-21.38M. See Immunicum AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 28.49M | $ 3.00M | $ 6.00K | |
| $ -6.29M | $ -6.52M | $ 28.49M | $ -1.85M | $ -1.84M | |
| $ 113.49M | $ 128.63M | $ 123.40M | $ 134.70M | $ 129.28M | |
| Depreciation and Amortization | $ 6.29M | $ 6.50M | $ 6.29M | $ 4.85M | $ 1.85M |
| $ -113.97M | $ -120.68M | $ -94.92M | $ -128.67M | $ -128.28M | |
| $ -120.26M | $ -135.15M | $ -100.65M | $ -133.68M | $ -130.10M | |
| $ 7.00M | $ 6.75M | $ -969.00K | $ -5.10M | $ -3.31M | |
| $ -113.26M | $ -128.40M | $ -101.62M | $ -138.78M | $ -133.41M | |
| $ -113.26M | $ -128.40M | $ -101.62M | $ -136.99M | $ -136.69M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.17 | $ -2.64 | $ -4.40 | $ -0.63 | $ -0.68 |
| Diluted EPS | $ -2.17 | $ -2.64 | $ -4.39 | $ -0.63 | $ -0.68 |
| Weighted Average Shares Outstanding | 52.19M | 48.64M | 23.10M | 216.49M | 199.75M |
| Weighted Average Shares Outstanding (Diluted) | 52.19M | 48.64M | 23.13M | 216.49M | 199.75M |
Currency in SEK
